Bahija Jallal

CIK: 0001730038

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (12.5%)

Position reduction

Option Exercises (M)1 (12.5%)

Derivative conversions

Awards (A)6 (75.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ELV

Elevance Health, Inc.

Director

IMCR

Immunocore Holdings plc

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (8 total)

ELV
Elevance Health, Inc.
May 13, 2026
Award(A)
Direct
563 shares-
IMCR
Immunocore Holdings plc
Feb 18, 2026
Sale(S)
Direct
11.5K shares at avg. $32.35$371K
IMCR
Immunocore Holdings plc
Feb 17, 2026
Award(A)
Employee Share Option (Right to Buy)
Direct
395.1K shares-
IMCR
Immunocore Holdings plc
Feb 17, 2026
Exercise(M)
Direct
23.8K shares-
IMCR
Immunocore Holdings plc
Feb 17, 2026
Award(A)
Restricted Share Units
Direct
88.6K shares-
ELV
Elevance Health, Inc.
May 14, 2025
Award(A)
Direct
601 shares-
IMCR
Immunocore Holdings plc
Feb 17, 2025
Award(A)
Restricted Share Units
Direct
95.3K shares-
IMCR
Immunocore Holdings plc
Feb 17, 2025
Award(A)
Employee Share Option (Right to Buy)
Direct
405.8K shares-

		Type	Shares	Price		Ownership
May 13, 2026	ELV Elevance Health, Inc.	Award(A)	563	-	$0	Direct
Feb 18, 2026	IMCR Immunocore Holdings plc	Sale(S)	11,474	$32.35	$371,184	Direct
Feb 17, 2026	IMCR Immunocore Holdings plc	Award(A) Employee Share Option (Right to Buy)	395,066	-	-	Direct
Feb 17, 2026	IMCR Immunocore Holdings plc	Exercise(M)	23,817	-	$0	Direct
Feb 17, 2026	IMCR Immunocore Holdings plc	Award(A) Restricted Share Units	88,573	-	-	Direct
May 14, 2025	ELV Elevance Health, Inc.	Award(A)	601	-	-	Direct
Feb 17, 2025	IMCR Immunocore Holdings plc	Award(A) Restricted Share Units	95,270	-	-	Direct
Feb 17, 2025	IMCR Immunocore Holdings plc	Award(A) Employee Share Option (Right to Buy)	405,824	-	-	Direct

1-8 of 8 transactions

About Jallal Bahija

Jallal Bahija (SEC CIK 0001730038) files insider reports with the SEC as Director of Elevance Health, Inc. (ELV) and CHIEF EXECUTIVE OFFICER of Immunocore Holdings plc (IMCR).

Signal8 holds 4 ownership filings by Jallal Bahija, all Form 4s, filed between Feb 19, 2025 and May 15, 2026. Those filings report 8 transactions, from Feb 17, 2025 to May 13, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Jallal Bahija's filings is in ABINGDON, OXFORDSHIRE, X0.

Recent filings by Jallal Bahija

May 13, 2026: Grant or award of ELV shares (Form 4, code A).
Feb 18, 2026: Open-market sale of IMCR shares (Form 4, code S).
Feb 17, 2026: Grant or award of IMCR derivative securities (Form 4, code A).
Feb 17, 2026: Option exercise of IMCR shares (Form 4, code M).
Feb 17, 2026: Grant or award of IMCR derivative securities (Form 4, code A).

Other insiders filing for Elevance Health, Inc. (ELV)

Kaye Mark, EVP & CFO
Wessling Erin M, EVP & Chief Legal Officer
Craig Ryan R, EVP & Chief HR Officer
PERU RAMIRO G, Director
BOUDREAUX GAIL, President and CEO
Penczek Ronald W, CAO & Controller

How to read Form 4 transaction codes